Lucentis: Clinical Trials

6 trials of Lucentis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated. 6 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Terminated 6
Phase 32Terminated 2
Phase 11Terminated 1

Follow Lucentis: new trials by email Literature Review of Lucentis trials Research Report on Lucentis

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Study of Zimura in Combination With Anti-VEGF Therapy in Patients With Neovascular AMD
Avacincaptad Pegol, Avastin, Lucentis - Neovascular Age-Related Macular Degeneration
Phase 2TerminatedIVERIC bio, Inc.12016-10-202025-03-13
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab
ranibizumab - Age-Related Macular Degeneration
Phase 2 / Phase 3TerminatedUniversity of California, San Diego202011-07-012019-08-28
A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)
Ranibizumab - Age Related Macular Degeneration, Choroidal Neovascular Membrane
Phase 1 / Phase 2TerminatedDavid M. Brown, M.D.882009-12-012017-01-02
Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration
Sirolimus in combination with ranibizumab, Placebo in combination with ranibizumab - Age-Related Macular Degeneration, Choroidal Neovascularization
Phase 2TerminatedSanten Inc.622008-12-012013-01-10
Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)
Verteporfin Photodynamic Therapy, Ranibizumab, Placebo - Macular Degeneration, Choroidal Neovascularization
Phase 2 / Phase 3TerminatedNovartis2552007-05-012011-04-21
Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)
ranibizumab - Proliferative Diabetic Retinopathy, Macular Edema
Phase 2TerminatedJumper, J. Michael, M.D.62007-03-012019-03-05

Conditions studied

Macular Degeneration (4)  ·  Choroidal Neovascularization (3)  ·  Eye Diseases (1)  ·  Macular Edema (1)  ·  Retinal Degeneration (1)  ·  Retinal Diseases (1)

Sponsors

David M. Brown, M.D. (1)  ·  IVERIC bio, Inc. (1)  ·  Jumper, J. Michael, M.D. (1)  ·  Novartis (1)  ·  Santen Inc. (1)  ·  University of California, San Diego (1)

Countries

United States (4)  ·  Austria (1)  ·  Belgium (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

David M Brown, MD (1)  ·  Henry Ferreyra, MD (1)  ·  J. Michael Jumper, M.D. (1)  ·  Joel Naor, MD (1)

Results publications

PMID 22424834, PMID 25079064